GRF:BME
Grifols SA Class A
€10,90
arrow_downward
-1,40%(-0,16) 1D
20 Nov., 17:36:00 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GRF...
Open
€10,95
High
€11,04
Low
€10,82
Mkt. cap
6,48Â mjd.
Avg. vol.
1,87Â m.
Volume
1,41Â m.
Dividend
2,13%
Quarterly dividend
€0,06
Ex-dividend date
02 Des. 2026
P/E ratio
15,34
52-wk high
€11,73
52-wk low
€8,43
EPS
€0,71
Shares outstanding
426,13Â m.
No. of employees
25Â k
Open
€10,95
High
€11,04
Low
€10,82
Mkt. cap
6,48Â mjd.
Avg. vol.
1,87Â m.
Volume
1,41Â m.
Dividend
2,13%
Quarterly dividend
€0,06
Ex-dividend date
02 Des. 2026
P/E ratio
15,34
52-wk high
€11,73
52-wk low
€8,43
EPS
€0,71
Shares outstanding
426,13Â m.
No. of employees
25Â k
News stories
From web sources and news partners
Yahoo Finance
·
1 uur gelede
The S&P 500 and Dow Jones Are Dangerously Close to Joining the Nasdaq in a Correction. Here’s the Level That Would Put the Nasdaq in a Bear Market, and What History Says Investors Should Do During a Stock Market Crash.
The Motley Fool
·
11 uur gelede
The S&P 500 Is 14 for 14 After Midterm Elections. Here’s How I’d Invest Now.
24/7 Wall St.
·
22 uur gelede
His Indexed Annuity Tracks the S&P 500. The Fine Print Says "Price Return," Which Means It Leaves Out Every Dividend the 500 Companies Pay
WSJ
·
2 dae gelede
Dow, S&P 500 Poised to Close at a Correction
Profile
Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Catalonia, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over 30.
Principally a producer of blood plasma–based products and other biopharmaceuticals, the company also operates in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, as well as clinical diagnostic technologies. Furthermore, it provides biological supplies for life-science research, clinical trials and the manufacturing of pharmaceutical and diagnostic products. It has a portfolio on four therapeutic areas: immunology, infectious diseases, pulmonology and critical care. Wikipedia
About Grifols SA Class A
CEONacho Abia
Employees25Â k
Founded18 Nov. 1940
Headquarters-
SectorHealth Care
Industry-
Websitegrifols.com